Pan-Lin Capital
Venture capitalShanghai · Pre-Seed–Growth
Investment thesis
Pan-Lin Capital invests under the theme 'technology creates the future, innovation leads upgrades,' concentrating on two areas: healthcare and biotech, and AI and technology. It targets early-stage deals from angel to Series A, aiming to find entrepreneurial scientists and innovative entrepreneurs. The firm follows a 'boutique investing' methodology: gaining early insight into industry trends, new technologies and business models; selecting individual targets rather than chasing sectors; leading rounds and providing hands-on post-investment value-add across business model, team building, resource connections and financing planning; and adding capital across multiple rounds in its strongest companies. It reports 10+ portfolio IPOs and 30+ industry leaders/unicorns.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 27 of 102 portfolio companiesBiotech ×14Healthtech ×13Deep Tech ×8Hardware ×6Medical Devices ×5Semiconductors ×4Robotics ×3Advanced Manufacturing ×2
HQs:China×18United States×2
Investments · 102 tracked
founders shown can be your intro pathOphthalmic contact lens care innovation company
Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer.
BiotechHealthtechFoster City, US
Hung-Wen (Howard) Chen(Executive Officer, Director)Hung-Hsien Yen(Director)Yi-Kuei (Alex) Chen(Executive Officer, Director)Hong-Jung (Moses) Chen(Director)Hsien-Shu (Jerry) Tsai(Director)Ya-Chi (Claudia) Huang(Director)
Co-investorsMaxpro VenturesQiming Venture Partners
Gaoneng Environment (高能环境, stock code 603588) is a publicly listed Chinese environmental services company operating in areas such as environmental remediation and waste treatment.
Circular EconomyCleantechClimate Tech
Biokangtai develops and manufactures human vaccines, including a 13-valent pneumococcal polysaccharide conjugate vaccine, a four-dose freeze-dried human rabies vaccine (human diploid cell), a combined acellular DTP–Hib vaccine, and a 60µg hepatitis B vaccine.
BiotechHealthtech
BioYond builds lab robotics and automation systems — including pipetting robots, transfer robots, and integrated automated benchtop and vertical platforms — using robotics, automation, and AI for liquid handling and material transport.
AI & Machine LearningBiotechRobotics
Co-investorsQiming Venture Partners
Chip Analog designs high-performance analog semiconductors, including isolation and interface products, digital isolators, isolated sampling and drivers, signal chain, sensor, and power management chips.
Deep TechHardwareSemiconductors
Cothera Bioscience is a clinical-stage biotech company developing cancer therapeutics aimed at previously undruggable oncology targets, using a translational platform based on synthetic lethality and protein degradation pathways.
BiotechDeep TechHealthtechSan Mateo, US
Shitong Microelectronics designs and develops machine-vision sensing chips, with a focus on high-precision, low-power, cost-competitive 3D sensors based on SPAD dToF technology.
Deep TechHardwareSemiconductorsShanghai, CN
Co-investorsLinear Capital
EasylogicEDA (Easylogic Technology, founded 2013) develops electronic design automation (EDA) software, focused on functional ECO (Engineering Change Order) algorithms for ASIC design teams.
Deep TechDeveloper ToolsSemiconductorsShenzhen, CN
A Chinese "internet + packaging" platform (小象智造) that provides online, end-to-end custom packaging services, from brand strategy and design to production.
Advanced ManufacturingE-commerceSaaS
Genfleet Therapeutics (HK: 2595) is a drug development company focused on oncology and immunological diseases, building large- and small-molecule pipelines targeting novel, clinically unvalidated targets and indications.
BiotechHealthtech
Co-investorsHM Venture Partners
Kaipu (Kepu) operates a network of medical laboratories and inspection centers across China and Hong Kong, providing clinical diagnostic testing services, including infectious disease and COVID-19 testing.
BiotechHealthtechMedical Devices
Guangdong Hybribio Biotech is a Chinese developer and supplier of nucleic acid molecular diagnostic products, focused on the R&D, production, and sale of molecular diagnostic reagents and instruments, including HPV genotyping detection kits and gene chips.
BiotechHealthtechMedical Devices
Co-investorsFortune Venture Capital
Iris Technologies (润雅) provides a full-business-chain ERP system, big-data private-domain e-commerce, and shared financial services for automotive retail enterprises.
Enterprise SoftwareRetail TechSaaS
Lingtaike Biotech develops nucleic acid drugs based on lncRNA, using its proprietary lncRNA-mediated targeting chimera technology (lncTAC) combined with the UNAST platform to target traditionally undruggable disease targets.
BiotechDeep TechChengdu, CN
宋旭(Professor / Founder)
Neukio is a biopharmaceutical company developing iPSC-derived cell technology platforms and next-generation off-the-shelf, mass-producible immune cell products (such as NK cells) to treat solid tumors and autoimmune diseases.
BiotechDeep TechHealthtech
Liqun Wang(Founder)
Osmunda provides incubation services for medical device companies, including its OLABS innovation facility.
HealthtechMedical Devices
Percipio (图漾科技) develops 3D machine vision products, including industrial 3D cameras, a low-code robot vision software platform (RVS), and integrated solutions for tasks such as object recognition, localization, guidance, and measurement.
HardwareLogistics & Supply ChainRobotics
Quanten Technologies develops electric motor and drive systems, including smart multi-phase motors, modular inverters, and control algorithms based on a software-defined electric drive architecture.
HardwareMobility & TransportationRobotics
Ribo Life Science (Ribocure/瑞博生物, HKEX: 06938.HK) develops RNA interference (RNAi) technology and industrializes small nucleic acid (siRNA) drugs, with an integrated research platform covering delivery and chemical modification technologies.
BiotechDeep TechHealthtech
Co-investorsBlue Ocean Capital Group
A Chinese cold-chain logistics provider offering refrigerated delivery, warehousing, integrated warehousing-distribution, and full-truckload transport, along with less-than-truckload networks and cloud warehouse services.
FoodTechLogistics & Supply Chain
灵动芯光 (SmartCore) is a silicon photonics company developing chip-to-chip optical interconnect technology, including its SmartComb multi-wavelength dense-wave light source and SmartPHY optical I/O chiplet.
Deep TechHardwareSemiconductors
Co-investorsQiming Venture Partners
Tinker Bio (霆科生物) develops microfluidics-based laboratory instruments, including an organ-on-a-chip culture and fluid control system (MOI-200), an automated microfluidic droplet generation system (DPS-300PRO), and a high-throughput microsphere preparation system (MSF-100).
BiotechHardwareMedical Devices
Unixell Biotechnology develops next-generation cell therapies based on human pluripotent stem cells, with a pipeline focused on major neurodegenerative diseases.
BiotechHealthtech
YesMRO operates an online B2B marketplace selling industrial maintenance, repair, and operations (MRO) supplies such as sensors, PLCs, relays, circuit breakers, pneumatic valves, connectors, and other automation components from brands like Schneider, Siemens, Panasonic, and SMC.
Advanced ManufacturingB2B MarketplacesE-commerce
Co-investors01vcQiming Venture Partners
Wuhan YZY Biopharma is a biotechnology company developing bispecific antibody (BsAb) therapies to treat cancer, cancer-related complications, and age-related ophthalmic diseases.
BiotechHealthtechWuhan, CN
Co-investorsBosch VenturesRobert Bosch Venture Capital
SPAD dToF photoelectric sensor chip designer
Next-gen synthetic lethality drug development company
Tumor microenvironment-responsive drug R&D platform
Tumor immunology bispecific antibody drug R&D company
Industrial-grade drone R&D and manufacturing company
Next-gen commercial vehicle smart diagnostic equipment leader
Leader in cervical cancer screening (300639)
Global-new drug development company (2595.HK)
World-class oncolytic virus company
EDA front-end technology R&D company
Intelligent automation company for life sciences
Packaging and printing industrial internet platform
Restaurant SaaS platform (acquired by Meituan-Dianping)
High-end analog chip innovator
Gene sequencing genetic disease diagnostics leader (acquired)
MRO e-commerce for small businesses
iPSC-CAR-NK cell therapy product R&D company
Stem-cell directed differentiation regenerative islet R&D company
China's first smart projector stock (688696)
AI defect detection solution provider
eVTOL and aerial robotics total solution provider
Automotive retail business intelligence big data platform
Pharmaceutical supply chain platform
Smart cold-chain logistics service platform
China small nucleic acid (siRNA) leader (6938.HK)
Brain-penetrant targeted drug R&D company
High-end communication chip R&D company
Innovative drug R&D for multiple tumors
Innovative oncology drug R&D company
Piezoelectric MEMS microphone R&D and manufacturing company
rAAV gene therapy drug R&D company
Novel nucleic acid self-assembly technology developer
Pathology AI diagnostics company
High-end structural heart disease medical device innovator
Industrial internet turnkey solution provider
Ultra-high-sensitivity genomics and molecular diagnostics company
Small-caliber regenerative blood vessel R&D company
Environmental systems service provider (603588)
Frequently asked questions
- How many investments has Pan-Lin Capital made?
- Pan-Lin Capital has 103 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does Pan-Lin Capital invest at?
- Pan-Lin Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Pan-Lin Capital focus on?
- Pan-Lin Capital focuses on AI & Machine Learning, Biotech, Cleantech, Consumer, Deep Tech, Enterprise Software, Healthtech, Logistics & Supply Chain, Medical Devices, Robotics, SaaS, Semiconductors.
- Where is Pan-Lin Capital located?
- Pan-Lin Capital is headquartered in Shanghai, CN.
- Does Pan-Lin Capital lead rounds?
- Yes, Pan-Lin Capital leads investment rounds.
- Who does Pan-Lin Capital co-invest with?
- Pan-Lin Capital most often shares deals with Qiming Venture Partners, Bosch Ventures, Monk's Hill Ventures, among 16 tracked co-investors.
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.